Contact this trialFirst, we need to learn more about you.
Long-acting Insulin
Insulin degludec 100 U/mL +1 More for Type 2 Diabetes
Recruiting3 awardsPhase 4
Lawrenceville, Georgia
This trial is designed to compare the efficacy and safety of two diabetes treatments, Gla-300 and IDeg-100, in insulin-naïve patients with Type 2 Diabetes Mellitus and renal impairment. The hypothesis is that Gla-300 is non-inferior to IDeg-100 in terms of glucose control. If achieved, the trial will also test for the superiority of Gla-300 compared with IDeg-100 in terms of reducing Hemoglobin A1c levels, without an increased potential risk of hypoglycemia.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.